The evaluation of efficacy for remission maintenance with immunomodulator following remission induction with tacrolimus in patients with moderate to severe active refractory ulcerative colitis.:mucosal healing for prognosis
Not Applicable
- Conditions
- The patients with moderate to severe active refractory ulcerative colitis
- Registration Number
- JPRN-UMIN000004201
- Lead Sponsor
- Osaka City University, Graduate School of Medicine,Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)The treatment with immunomodulator or anti-TNF alpha agents within 12 weeks before administration of tacrolimus 2)The treatment with cytapheresis within 12 weeks before administration of tacrolimus 3)The patients who are not suitable for treatment of immunomodulator 4)The patients after colectomy 5)the patients with renal disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method